Analpram HC NDC 83107-019

NDC codes

FDA NDC Directory

Product NDC (as listed)83107-019Labeler and product segments. Claims need a package NDC.

Product NDC at billing width83107-0019Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
83107-019-12	83107001912	12 TUBE, WITH APPLICATOR in 1 CARTON (83107-019-12) / 4 g in 1 TUBE, WITH APPLICATORMarketed from Jul 25, 2025
83107-019-30	83107001930	30 TUBE, WITH APPLICATOR in 1 CARTON (83107-019-30) / 4 g in 1 TUBE, WITH APPLICATORMarketed from Jul 25, 2025

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Analpram HC
Generic name (nonproprietary): hydrocortisone acetate and pramoxine hydrochloride
Active ingredients: Hydrocortisone acetate — 25 mg/gPramoxine hydrochloride — 10 mg/g
Dosage form: Cream
Route: Topical
Labeler: Legacy Pharma USA Inc.
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 085979
Marketing start: Jul 25, 2025
Listing expires: Dec 31, 2027
Other FDA classes: Corticosteroid Hormone Receptor Agonists (Mechanism)
Identifiers: Product ID 83107-019_4dcbb97c-b493-022f-e063-6294a90ac089SPL ID 4dcbb97c-b493-022f-e063-6294a90ac089SPL set ID 3e5c6728-ece3-40f7-9e36-cff71f168cd8RxCUI 1294025, 1362211UNII 3X7931PO74, 88AYB867L5UPC 0383107019015
Pharmacologic class: Corticosteroid

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Topical products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N483107001912 followed by a unit qualifier and the quantity

Package 83107-0019-12. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Mar 24, 2026.

Indications (excerpt from the label)

INIDCATIONS AND USAGE: Topical corticosteroids are indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 085979

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 085979
Product	Strength	Form · route	Labeler	Product NDC
Analpram HChydrocortisone acetate and pramoxine hydrochloride	Hydrocortisone acetate 25 mg/mL; Pramoxine hydrochloride 10 mg/mL	LotionTopical	Sebela Pharmaceuticals Inc.	54766-829
Pramosonehydrocortisone acetate and pramoxine hydrochloride	Hydrocortisone acetate 25 mg/mL; Pramoxine hydrochloride 10 mg/mL	LotionTopical	Legacy Pharma USA Inc.	83107-021
Analpram HChydrocortisone acetate and pramoxine hydrochloride	Hydrocortisone acetate 25 mg/mL; Pramoxine hydrochloride 10 mg/mL	LotionTopical	Legacy Pharma USA Inc.	83107-020